标准化测试用于监测血液癌症中药物敏感性的标准化测试

Pilar Ayuda-Durán1,2, Johanne U Hermansen3,4, Mariaserena Giliberto3,4

  • 1Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.

Cell death discovery
|December 1, 2023
PubMed
概括

针对AML,CLL和MM等血液癌症的优化药物敏感性测试协议提高了ex vivo准确性. 这些经过验证的方法有助于实时治疗指导和标准化,以获得更好的患者结果.